The prognostic significance of APC gene mutation and miR-21 expression in advanced-stage colorectal cancer

Colorectal Disease

Volumn 15, Issue 11, 2013, Pages 1367-1374

  Chen, T H ^a,b   Chang, S W ^a,b   Huang, C C ^a,b   Wang, K L ^a,d   Yeh, K T ^a,c   Liu, C N ^a   Lee, H ^d   Lin, C C ^a,b   Cheng, Y W ^d  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

APC; MiR 21; Prognostic factor

Indexed keywords

MICRORNA 21;

ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER TISSUE; COLORECTAL CANCER; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WILD TYPE;

APC; MIR-21; PROGNOSTIC FACTOR;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AGED; COLORECTAL NEOPLASMS; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, APC; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MUTATION; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RNA, MESSENGER; SURVIVAL RATE; WNT SIGNALING PATHWAY;

EID: 84887149689     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/codi.12318     Document Type: Article

References (38)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60: 277-300.
2. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma-carcinoma sequence. Br J Surg 2002; 89: 845-60.
3. Kinzler KW, Nilbert MC, Vogelstein B et al. Identification of a gene located at chromosome 5q21 that is mutated in colorectal cancers. Science 1991; 251: 1366-70.
4. Fodde R, Smits R, Clevers H. APC, signal transduction and genetic instability in colorectal cancer. Nat Rev Cancer 2001; 1: 55-67.
5. Burgess AW, Faux MC, Layton MJ, Ramsay RG. Wnt signaling and colon tumorigenesis - a view from the periphery. Exp Cell Res 2011; 317: 2748-58.
6. He TC, Sparks AB, Rago C et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
7. Tetsu O, McCormuck F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
8. Slack FJ, Weidhaas JB. MicroRNA in cancer prognosis. N Engl J Med 2008; 359: 2720-2.
9. Hede K. Small RNAs are raising big expectations. J Natl Cancer Inst 2009; 101: 840-1.
10. Volinia S, Calin GA, Liu CG et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-61.
11. Alder H, Taccioli C, Chen H et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012; 33: 1736-44.
12. Niu J, Shi Y, Tan G et al. DNA damage induces NF-κB-dependent microRNA-21 up-regulation and promotes breast cancer cell invasion. J Biol Chem 2012; 287: 21783-95.
13. Yu Y, Kanwar SS, Patel BB et al. MicroRNA-21 induces stemness by downregulating transforming growth factor beta receptor 2 (TGFβR2) in colon cancer cells. Carcinogenesis 2012; 33: 68-76.
14. Ma X, Kumar M, Choudhury SN et al. Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis. Proc Natl Acad Sci USA 2011; 108: 10144-9.
15. Ren J, Zhu D, Liu M, Sun Y, Tian L. Downregulation of miR-21 modulates Ras expression to promote apoptosis and suppress invasion of laryngeal squamous cell carcinoma. Eur J Cancer 2010; 46: 3409-16.
16. Medina PP, Nolde M, Slack FJ. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010; 467: 86-90.
17. Lan F, Yue X, Han L et al. Genome-wide identification of TCF7L2/TCF4 target miRNAs reveals a role for miR-21 in Wnt-driven epithelial cancer. Int J Oncol 2012; 40: 519-26.
18. Moskaluk CA, Kern SE. Microdissection and polymerase chain reaction amplification of genomic DNA from histological tissue sections. Am J Pathol 1997; 150: 1547-52.
19. Minde DP, Anvarian Z, Rüdiger SG, Maurice MM. Messing up disorder: how do missense mutations in the tumor suppressor protein APC lead to cancer? Mol Cancer 2011; 10: 101.
20. Newton KF, Newman W, Hill J. Review of biomarkers in colorectal cancer. Colorectal Dis 2012; 14: 3-17.
21. Conlin A, Smith G, Carey FA, Wolf CR, Steele RJ. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut 2005; 54: 1283-6.
22. Xu XM, Qian JC, Cai Z et al. DNA alterations of microsatellite DNA, p53, APC and K-RAS in Chinese colorectal cancer patients. Eur J Clin Invest 2011; 42: 751-9.
23. Jeo CH, Lee HI, Shin IH, Park JW. Genetic alterations of APC, K-RAS, p53, MSI, and MAGE in Korean colorectal cancer patients. Int J Colorectal Dis 2008; 23: 29-35.
24. Chiang JM, Chou YHW, Ma SC, Chen JR. Influence of age on adenomatous polyposis coli and p53 mutation frequency in sporadic colorectal cancer-rarity of co-occurrence of mutation in APC, K-RAS, and p53 status. Virchows Arch 2004; 445: 465-71.
25. Wang JY, Hsieh JS, Lu CY et al. The differently mutational spectra of APC, K-RAS, and p53 genes in sporadic colorectal cancer from Taiwanese patients. Hepatogastroenterology 2007; 54: 2259-65.
26. Akiyama Y, Nagasaki H, Yagi KO, Nomizu T, Yuasa Y. Beta-catenin and adenomatous polyposis coli (APC) mutations in adenomas from hereditary non-polyposis colorectal cancer patients. Cancer Lett 2000; 157: 185-91.
27. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 2007; 9: 165-70.
28. Wang YC, Chen CY, Chen SK, Cherng SH, Ho WL, Lee H. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan. Cancer Res 1998; 58: 328-33.
29. Kunkel TA. DNA replication fidelity. J Biol Chem 1992; 267: 18251-4.
30. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993; 363: 558-61.
31. Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. MS-920: DNA repair gene polymorphisms, diet and colorectal cancer risk in Taiwan. Cancer Lett 2005; 224: 279-88.
32. Bau DT, Yang MD, Tsou YA, Chang-Chieh CR, Sung FC. Colorectal cancer and genetic polymorphism of DNA double-strand break repair gene XRCC4 in Taiwan. Anticancer Res 2010; 30: 2727-30.
33. Huang MY, Fang WY, Lee SC, Cheng TL, Wang JY, Lin SR. ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. BMC Cancer 2008; 8: 50.
34. Walther A, Johnstone E, Swanton C, Midgley R, Tomlinson I, Kerr D. Genetic prognostic and predictive markers in colorectal cancer. Nat Rev Cancer 2009; 9: 489-99.
35. Huang K, Zhang JX, Han L et al. MicroRNA roles in beta-catenin pathway. Mol Cancer 2010; 9: 252.
36. Nielsen BS, Jørgensen S, Fog JU et al. High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients. Clin Exp Metastasis 2011; 28: 27-38.
37. Liu K, Li G, Fan C, Zhou X, Wu B, Li J. Increased expression of microRNA-21 and its association with chemotherapeutic response in human colorectal cancer. J Int Med Res 2011; 39: 2288-95.
38. Shibuya H, Iinuma H, Shimada R, Horiuchi A, Watanabe T. Clinicopathological and prognostic value of microRNA-21 and microRNA-155 in colorectal cancer. Oncology 2010; 79: 313-20.